Sparks fly in advance of FDA meeting to examine Bayer contraceptives
07 December 2011
Donna Young
Please Login to read the full article.
07 December 2011
Donna Young
Please Login to read the full article.
RELATED CONTENT
NEWS
- FDA panel: Benefits of Bayer's Yaz/Yasmin outweigh risks, but labels need revision
- Watson launches generic contraceptive in midst of Yaz controversy
- US Capitol Capsule: Supreme Court takes another stab at refining US patent law
- US FDA reviewing blood clot risk with Bayer's Yaz, other birth control pills
COMMENT
Other Informa Comment
EVENTS
Today
The Rembrandt Hotel, London
07 June 2012
The Rembrandt Hotel, London
12 June 2012
Annecy, France
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
